| ATC codes |
|---|
| C Cardiovascular system |
| C01 Cardiac therapy |
| C02 Antihypertensives |
| C03 Diuretics |
| C04 Peripheral vasodilators |
| C05 Vasoprotectives |
| C07 Beta blocking agents |
| C08 Calcium channel blockers |
| C09 Agents acting on the renin-angiotensin system |
| C10 Lipid modifying agents |
|
|
ATC code C08 Calcium channel blockers is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup C08 is part of the anatomical group C Cardiovascular system.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QC08...[2]
Contents |
C08C Selective calcium channel blockers with mainly vascular effects
C08CA Dihydropyridine derivatives
- C08CA01 Amlodipine
- C08CA02 Felodipine
- C08CA03 Isradipine
- C08CA04 Nicardipine
- C08CA05 Nifedipine
- C08CA06 Nimodipine
- C08CA07 Nisoldipine
- C08CA08 Nitrendipine
- C08CA09 Lacidipine
- C08CA10 Nilvadipine
- C08CA11 Manidipine
- C08CA12 Barnidipine
- C08CA13 Lercanidipine
- C08CA14 Cilnidipine
- C08CA15 Benidipine
- C08CA55 Nifedipine, combinations
C08CX Other selective calcium channel blockers with mainly vascular effects
- C08CX01 Mibefradil
C08D Selective calcium channel blockers with direct cardiac effects
C08DA Phenylalkylamine derivatives
- C08DA01 Verapamil
- C08DA02 Gallopamil
- C08DA51 Verapamil, combinations
C08DB Benzothiazepine derivatives
- C08DB01 Diltiazem
C08E Non-selective calcium channel blockers
C08EA Phenylalkylamine derivatives
C08EX Other non-selective calcium channel blockers
- C08EX01 Lidoflazine
- C08EX02 Perhexiline
C08G Calcium channel blockers and diuretics
C08GA Calcium channel blockers and diuretics
- C08GA01 Nifedipine and diuretics
References
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
